Some genetic disorders—such as cystic fibrosis, hemophilia and Tay Sachs disease—involve many mutations in a person's genome, ...

Biotech firm Metagenomi said it is using artificial intelligence chips from Amazon.com's cloud computing unit to power some ...

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

Researchers have developed an improved method of gene editing that is precise, more efficient than other similar methods and ...

We have the tech to make designer babies but we are not ready for it yet. Read more at straitstimes.com. Read more at straitstimes.com.

Biotech company Metagenomi ( NASDAQ: MGX) is utilizing artificial intelligence chips from Amazon Web Services ( AMZN) to ...

MIT scientists have found a way to make gene editing far safer and more accurate — a breakthrough that could reshape how we ...

A one-time gene-editing therapy, exagamglogene autotemcel (exa-cel), has demonstrated sustained and clinically meaningful ...

With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.

As a result, the technology stands at a complicated intersection in the fight against a shifting climate. Breeding plants to ...